American Heart Journal
Volume 143, Issue 6 , Pages 961-965, June 2002

Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study☆☆

Framingham and Boston, Mass, and Bethesda, Md

From the aNational Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Mass, the Sections of bGeneral Internal Medicine, cEndocrinology, and dPreventive Medicine, Boston University School of Medicine, Boston, Mass, and the eNational Heart, Lung, and Blood Institute, Bethseda, Md

Received 6 June 2001; accepted 28 December 2001.

Abstract 

Background Peripheral arterial disease (PAD) is associated with an increased risk for mortality. We sought to assess the prevalence of PAD and its risk factors in a population-based sample. Methods We examined 1554 males and 1759 females with a mean age of 59 years who attended a Framingham Offspring Study examination from 1995 to 1998. PAD was defined by an ankle-brachial blood pressure index of <0.9. Age- and sex-adjusted and multivariable logistic regression analyses were performed to identify factors associated with PAD. Results The prevalences of PAD, current intermittent claudication, lower extremity bruits and surgical intervention were 3.9%, 1.9%, 2.4% and 1.4% in males and 3.3%, 0.8%, 2.3% and 0.5% in females. Hypercholesterolemia, high-density lipoprotein cholesterol, triglyceride, diabetes, hypertension, current smoking, pack-years of smoking, body mass index, fibrinogen, and prevalent coronary disease were associated with PAD in age- and sex-adjusted analyses. Odds ratios and 95% CIs for significant associations identified from multivariable analyses are as follows: each 10 years of age, 2.6 (2.0, 3.4); hypertension, 2.2 (1.4, 3.5); smoking, 2.0 (1.1, 3.4); 10 pack-years of smoking, 1.3 (1.2, 1.4); 50 mg/dL of fibrinogen, 1.2 (1.1, 1.4); 5 mg/dL of high-density lipoprotein, 0.9 (0.8, 1.0); coronary disease, 2.6 (1.6, 4.1). Conclusions Smoking cessation and hypertension control are important goals in the aim to reduce PAD and its associated impact on quality of life, functional decline, and risk for subsequent cardiovascular disease. (Am Heart J 2002;143:961-5.)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Reprint requests: Joanne M. Murabito, MD, MSc, The Framingham Heart Study, 73 Mount Wayte Ave, Suite 2, Framingham, MA 01702-5827.

☆☆ E-mail: joanne@fram.nhlbi.nih.gov

PII: S0002-8703(02)00008-X

doi:10.1067/mhj.2002.122871

American Heart Journal
Volume 143, Issue 6 , Pages 961-965, June 2002